3 days popular7 days popular1 month popular3 months popular

SMi’s 6th Annual Biomarkers Summit 2013 – Innovations In Stratified Medicine
, 16-17 January 2013, London

Get all the details on imaging of to tumor adaptations and see all the new sessions, speakers and formats we’ve introduced to make SMi’s 6th Summit the best event in the pharmaceutical industry. Attend and stay competitive with fresh insights from companies at the cutting edge of biopharmaceutical .

SMi is pleased to confirm , Diagnostics Director, AstraZeneca as a speaker at the event. Jill will discuss Identifying patient subpopulations with improved response, adapting development strategies to deliver companion diagnostics and ensuring access to diagnostics

Conference Highlights:

  • Case studies in (IPF) and molecular characterisation of solid tumors
  • Interactive panel discussion focusing on current developments in personalised medicine via biomarkers
  • Latest advancements in and multi-centre clinical imaging studies 
  • New developments in pharmacogenetic and pharmacogenomic statistical study design
  • Future direction and initiatives for safety biomarkers
  • Maximise the cost-effectiveness of your companion diagnostic for end-users

For more information visit http://www.smi-online.co.uk/goto/biomarkers-summit81.asp alternatively contact Cem Tuna on +44 0 207 827 6184 or email on [email protected]